New York Life Investments Alternatives
Latest statistics and disclosures from Apogem Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACCD, and represent 100.00% of Apogem Capital's stock portfolio.
- Reduced shares in these 10 stocks: OEC (-$5.7M), ZETA (-$5.2M), BXC, GPRE, DBX, FOXA, OXM, S, Twitter, .
- Sold out of its positions in ACVA, Activision Blizzard, Aerojet Rocketdy, AKTS, Albireo Pharma, ALDX, BABA, GOOG, GOOGL, AMZN.
- Apogem Capital was a net seller of stock by $-100M.
- Apogem Capital has $303k in assets under management (AUM), dropping by -99.70%.
- Central Index Key (CIK): 0001845268
Tip: Access up to 7 years of quarterly data
Positions held by New York Life Investments Alternatives consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Apogem Capital
Apogem Capital holds 1 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Past Filings by Apogem Capital
SEC 13F filings are viewable for Apogem Capital going back to 2020
- Apogem Capital 2022 Q4 filed Feb. 13, 2023
- Apogem Capital 2022 Q3 filed Nov. 14, 2022
- Apogem Capital 2022 Q2 filed Aug. 15, 2022
- Apogem Capital 2022 Q1 filed May 16, 2022
- New York Life Investments Alternatives 2021 Q4 filed Feb. 14, 2022
- New York Life Investments Alternatives 2021 Q3 filed Nov. 15, 2021
- New York Life Investments Alternatives 2021 Q2 filed Aug. 16, 2021
- New York Life Investments Alternatives 2021 Q1 filed May 14, 2021
- New York Life Investments Alternatives 2020 Q4 filed Feb. 16, 2021